WuXi AppTec »

Castle Biosciences shares owned by WuXi AppTec

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by WuXi AppTec from 13F filings

Historical chart of WuXi AppTec investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by WuXi AppTec consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by WuXi AppTec

Quarter filed Position value Share count Share price at filing
2023-12-31 $143k 6.6k 21.58

More positions owned by WuXi AppTec

Lyell Immunopharma (LYEL)
Ambrx Biopharma
Adagene Ads (ADAG)
Purple Biotech Sponsored Ads (PPBT)
Castle Biosciences (CSTL)

View all positions for WuXi AppTec

Top funds holding Castle Biosciences

Daniel D. Thurber
Principal Financial Group
Vanguard Group
Bellevue Group
Deerfield Management Company
Portolan Capital Management
Millennium Management
Dimensional Fund Advisors
Kornitzer Capital Management
Palisade Capital Management
Jacobs Levy Equity Management
Citadel Advisors
New York State Common Retirement Fund
Charles Schwab Investment Management
Banque Pictet & Cie Sa

View all funds holding Castle Biosciences